HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.

Abstract
In a patient with metastatic Hurthle cell carcinoma of the thyroid, a subgroup of follicular carcinoma, scintigraphy with pentavalent 99mTc-labeled dimercaptosuccinic acid (V)DMSA showed a significant uptake of the radiopharmaceutical in all tumor sites. We suggest that the accumulation of 99mTc-(V)DMSA within metastases of Hurthle cell thyroid tumor may have a useful role in the staging of these patients, especially when radioiodine fails to concentrate.
AuthorsE Vergara, S Lastoria, P Varrella, L Lapenta, M Salvatore
JournalJournal of nuclear biology and medicine (Turin, Italy : 1991) (J Nucl Biol Med (1991)) Vol. 37 Issue 2 Pg. 65-8 (Jun 1993) ISSN: 0368-3249 [Print] Italy
PMID8396979 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Organotechnetium Compounds
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Succimer
Topics
  • Adenoma (diagnostic imaging)
  • Female
  • Humans
  • Middle Aged
  • Organotechnetium Compounds
  • Radionuclide Imaging
  • Succimer
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Thyroid Neoplasms (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: